Selcodebart

斯可德拜单抗

Report date: 2026/04/17 20:02:02

Base Information

Drug NameSelcodebart
Drug Alias NameDISC-0974
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionHemochromatosis type 2 protein inhibitors
TargetsHemochromatosis type 2 protein
Therapy Area/IndicationsPrimary MyelofibrosisMyeloproliferative DisordersMyelodysplastic Syndromes +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAbbvie Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPrimary MyelofibrosisMyeloproliferative DisordersMyelodysplastic Syndromes +[7
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A